scispace - formally typeset
I

Iain P. Hargreaves

Researcher at Liverpool John Moores University

Publications -  180
Citations -  9453

Iain P. Hargreaves is an academic researcher from Liverpool John Moores University. The author has contributed to research in topics: Mitochondrial disease & Coenzyme Q10. The author has an hindex of 42, co-authored 166 publications receiving 8044 citations. Previous affiliations of Iain P. Hargreaves include UCL Institute of Neurology & University College Hospital.

Papers
More filters
Journal ArticleDOI

Association between mitochondrial dysfunction and severity and outcome of septic shock

TL;DR: In septic patients, an association between nitric oxide overproduction, antioxidant depletion, mitochondrial dysfunction, and decreased ATP concentrations that relate to organ failure and eventual outcome is found.
Journal ArticleDOI

Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.

TL;DR: In this study, it is shown that FH-deficient cells and tumours accumulate fumarate and, to a lesser extent, succinate, and in situ analyses showed that these tumours also have over-expression of hypoxia-inducible factor 1alpha, activation of HIF1alphatargets, and high microvessel density.
Journal ArticleDOI

Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration

TL;DR: A novel role is demonstrated for Nrf2 in directly regulating mitochondrial bioenergetics in murine neurons and embryonic fibroblasts through modulating the availability of substrates for mitochondrial respiration and the importance of efficient energy metabolism in NRF2-mediated cytoprotection.
Journal ArticleDOI

PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons.

TL;DR: It is reported that PINK1 plays a neuroprotective role in the mitochondria of mammalian neurons, especially against stress such as staurosporine, and evidence that cellular compensatory mechanisms such as mitochondrial biogenesis and upregulation of lysosomal degradation pathways occur in Pink1 deficiency.